twoXAR Pharmaceuticals CEO Andrew A. Radin joins a webinar hosted by CM Life Sciences to discuss harnessing AI in drug discovery.

twoXAR Pharmaceuticals SVP Nonclinical R&D & Chemistry Anjali Pandey moderates a panel including twoXAR CEO Andrew Radin, along with representatives from Recursion Pharma, ATOM Consortium, and NuMedii.

twoXAR Pharmaceuticals CEO Andrew Radin presents on the company's capabilities in discovering first-in-class small molecules for oncology and more using AI.

twoXAR Pharmaceuticals CEO Andrew Radin presents and joins the JLabs panel to discuss how biology startups can partner with AI companies.

twoXAR Pharmaceuticals CEO, Andrew A. Radin, joins a panel on "What's Next: Investment, Partnerships, and Pushing Life Sciences Forward".

twoXAR Pharmaceuticals CEO Andrew Radin joins a panel to discuss AI across the drug development lifecycle.

twoXAR CEO Andrew Radin discusses how the company approaches drug discovery.

twoXAR Pharmaceuticals VP Discovery, Aaron Daugherty, joins DrugBank CEO Michael Wilson in an online fireside chat on using DrugBank data sources for drug discovery.

twoXAR Pharmaceuticals CEO, Andrew A. Radin, discusses the applications of AI in Drug Discovery.

twoXAR Pharmaceuticals CEO, Andrew A. Radin, discusses the applications of AI in Drug Discovery.